Karrie Wong

Karrie Wong serves as the Senior Director and Head of Cell Therapy at KSQ Therapeutics, Inc. since January 2021, with previous roles as Director and Head of Cell Therapy. Prior experience includes serving as Associate Director at Editas Medicine focusing on cell and gene therapy for oncology, and Senior Scientist specializing in immunogenetics and immuno-oncology. At Novartis Institutes for BioMedical Research, Karrie held positions as Investigator II and Investigator I in exploratory immune-oncology. A Postdoctoral Fellow at Dana-Farber Cancer Institute contributed to research in medical oncology under Dr. Glenn Dranoff, while Karrie's PhD research at the University of Toronto centered on the prognostic and therapeutic potential of CD200 in Chronic Lymphocytic Leukemia. Karrie's educational background includes a Postdoctoral Fellowship in Immuno-Oncology from Harvard Medical School and a PhD in Medical Science from the University of Toronto.